ClinicalTrials.govpublic full text
Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients
cryopyrin-associated periodic syndromes (caps), familial cold autoinflam syn (fcas), muckle-wells syn (mws), neonatal onset multisystem inflam disease (nomid), cryopyrin-associated periodic syndromes(caps), cias1 protein, nlrp3 protein, human cryopyrin protein, familial cold autoinflammatory syndrome(fcas), muckle-wells syndrome(mws), neonatal onset multisystem inflammatory disease(nomid), nalp3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 866115
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.